ArticleStroke and vascular neurology2026

Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial.

Nanxing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.